Nasdaq
SABS
SAB Biotherapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +2.1%
- 1 month
- −1.3%
- 1 year
- +75.8%
$3.85 · Mkt cap $294M
At the 6 Aug 2026 close
Nasdaq
SAB Biotherapeutics, Inc.
$3.85 · Mkt cap $294M
At the 6 Aug 2026 close
SAB Biotherapeutics, Inc. trades under the ticker SABS on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $294M. The last closing price was $3.85, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +75.8%, and −1.3% over the past month. Returns are price returns and exclude dividends.
This page exists because SABS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.